Estimating the generated business value of big data analytics dashboard for end users at a pharmaceutical company
Loading...
Authors
Author (Corporation)
Publication date
2023
Typ of student thesis
Bachelor
Course of study
Collections
Type
11 - Student thesis
Editors
Editor (Corporation)
Supervisor
Parent work
Special issue
DOI of the original publication
Link
Series
Series number
Volume
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Hochschule für Wirtschaft FHNW
Place of publication / Event location
Basel
Edition
Version
Programming language
Assignee
Practice partner / Client
Novartis, Basel
Abstract
The company introduced BDA to support clinical trials with an in-house-built dashboard and application on operational data. As the technology is still new to the industry, no long-term studies have demonstrated the value of BDA for a company. Traditional key performance metrics are unsuitable for measuring the value since BDA technology is more than just a system or application. Every year, the project team behind the big data dashboard has been asked to show the application’s value but has struggled to do so.
Keywords
Subject (DDC)
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Review
Open access category
License
Citation
Iselin, P. (2023). Estimating the generated business value of big data analytics dashboard for end users at a pharmaceutical company [Hochschule für Wirtschaft FHNW]. https://irf.fhnw.ch/handle/11654/42211